Free Trial

ScanSource (SCSC) Financials

ScanSource logo
$42.13 -0.34 (-0.80%)
Closing price 07/8/2025 04:00 PM Eastern
Extended Trading
$42.12 -0.01 (-0.02%)
As of 07/8/2025 05:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for ScanSource

Annual Income Statements for ScanSource

This table shows ScanSource's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 6/30/2014 6/30/2015 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024
Net Income / (Loss) Attributable to Common Shareholders
82 65 64 69 33 58 -193 11 89 90 77
Consolidated Net Income / (Loss)
82 65 64 69 33 58 -193 11 89 90 77
Net Income / (Loss) Continuing Operations
82 65 64 69 35 65 -79 45 89 88 77
Total Pre-Tax Income
123 100 96 101 63 84 -72 58 119 122 100
Total Operating Income
122 101 97 88 69 95 -65 61 122 136 90
Total Gross Profit
301 327 355 384 369 393 356 351 427 449 399
Total Revenue
2,914 3,219 3,540 3,568 3,165 3,250 3,048 3,151 3,530 3,788 3,260
Operating Revenue
2,914 3,219 3,540 3,568 3,165 3,250 3,048 3,151 3,530 3,788 3,260
Total Cost of Revenue
2,613 2,892 3,185 3,185 2,795 2,857 2,692 2,800 3,103 3,338 2,861
Operating Cost of Revenue
2,613 2,892 3,185 3,185 2,795 2,857 2,692 2,800 3,103 3,338 2,861
Total Operating Expenses
179 226 259 295 300 298 421 289 304 313 309
Selling, General & Admin Expense
192 211 240 265 232 244 260 247 275 286 277
Depreciation Expense
- 5.36 7.33 9.40 12 12 13 13 11 11 11
Amortization Expense
- 6.60 9.80 16 19 18 20 19 18 17 16
Restructuring Charge
- - - - - 8.65 0.60 9.26 0.00 0.00 4.36
Total Other Income / (Expense), net
1.32 -1.54 -0.87 13 -5.96 -11 -6.81 -3.95 -3.54 -14 9.52
Interest Expense
0.73 1.80 2.12 3.22 9.12 13 12 6.93 6.52 20 13
Interest & Investment Income
2.36 2.64 3.45 5.33 3.71 1.82 5.83 3.10 4.33 7.41 9.38
Other Income / (Expense), net
-0.31 -2.38 -2.19 11 -0.55 0.25 -0.41 -0.12 -1.35 -1.66 13
Income Tax Expense
41 34 32 32 28 19 7.45 12 30 34 23
Net Income / (Loss) Discontinued Operations
- - - - -2.30 -7.26 -113 -35 0.10 1.72 0.00
Basic Earnings per Share
$2.89 $2.29 $2.40 $2.74 $1.30 $2.25 ($7.59) $0.42 $3.48 $3.57 $3.10
Weighted Average Basic Shares Outstanding
28.34M 28.56M 26.47M 25.32M 25.52M 25.64M 25.38M 25.42M 25.50M 25.14M 24.87M
Diluted Earnings per Share
$2.86 $2.27 $2.38 $2.71 $1.29 $2.24 ($7.59) $0.42 $3.45 $3.54 $3.06
Weighted Average Diluted Shares Outstanding
28.60M 28.80M 26.69M 25.52M 25.62M 25.73M 25.38M 25.52M 25.76M 25.36M 25.22M
Weighted Average Basic & Diluted Shares Outstanding
28.30M 28.60M 26.50M 25.30M 25.50M 25.24M 25.36M 25.50M 25.19M 24.84M 24.03M

Quarterly Income Statements for ScanSource

This table shows ScanSource's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Income / (Loss) Attributable to Common Shareholders
24 26 21 19 15 33 13 16 17 17 17
Consolidated Net Income / (Loss)
24 26 21 19 15 33 13 16 17 17 17
Net Income / (Loss) Continuing Operations
24 26 21 17 15 33 13 16 17 17 17
Total Pre-Tax Income
32 36 30 23 19 40 18 23 23 20 24
Total Operating Income
35 39 34 27 24 27 18 22 18 18 22
Total Gross Profit
113 115 112 109 107 101 94 97 102 102 100
Total Revenue
944 1,011 886 947 876 885 753 746 776 747 705
Operating Revenue
944 1,011 886 947 876 885 753 746 776 747 705
Total Cost of Revenue
830 896 774 838 770 784 658 649 674 646 605
Operating Cost of Revenue
830 896 774 838 770 784 658 649 674 646 605
Total Operating Expenses
79 76 77 81 82 74 77 75 84 83 78
Selling, General & Admin Expense
72 69 71 74 75 67 67 68 72 74 70
Depreciation Expense
2.76 2.68 2.64 2.83 2.80 2.96 2.69 2.77 2.86 2.90 2.32
Amortization Expense
4.24 4.15 4.17 4.19 4.19 4.04 3.75 3.74 4.36 5.00 4.94
Restructuring Charge
- - 0.00 - 0.00 0.00 3.92 - 5.07 0.31 0.00
Other Special Charges / (Income)
- - - - - 0.00 0.00 - - 1.14 0.90
Total Other Income / (Expense), net
-2.61 -3.24 -4.37 -3.83 -4.94 13 0.41 0.82 5.33 1.27 1.89
Interest Expense
3.45 5.06 5.72 5.56 5.59 3.36 2.00 2.09 2.11 1.97 1.84
Interest & Investment Income
1.59 2.03 1.71 2.09 1.33 2.12 2.65 3.29 2.66 2.69 2.84
Other Income / (Expense), net
-0.75 -0.21 -0.36 -0.35 -0.68 14 -0.24 -0.38 4.78 0.54 0.88
Income Tax Expense
8.24 10 8.69 6.37 3.72 7.32 5.15 6.60 5.99 2.66 6.80
Basic Earnings per Share
$0.95 $1.02 $0.84 $0.76 $0.62 $1.31 $0.51 $0.66 $0.70 $0.72 $0.75
Weighted Average Basic Shares Outstanding
25.20M 25.29M 25.20M 25.14M 24.89M 25.04M 25.03M 24.87M 24.15M 23.81M 23.28M
Diluted Earnings per Share
$0.94 $1.01 $0.83 $0.76 $0.61 $1.29 $0.50 $0.66 $0.69 $0.70 $0.74
Weighted Average Diluted Shares Outstanding
25.45M 25.50M 25.44M 25.36M 25.18M 25.33M 25.44M 25.22M 24.65M 24.22M 23.60M
Weighted Average Basic & Diluted Shares Outstanding
25.25M 25.35M 24.90M 24.84M 24.97M 25.17M 24.71M 24.03M 0.00 23.46M 22.60M

Annual Cash Flow Statements for ScanSource

This table details how cash moves in and out of ScanSource's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 6/30/2014 6/30/2015 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024
Net Change in Cash & Equivalents
47 -73 -60 -4.87 -35 -1.71 11 28 -25 -1.81 149
Net Cash From Operating Activities
48 76 52 95 25 16 182 117 -124 -36 372
Net Cash From Continuing Operating Activities
48 76 52 95 31 16 182 117 -124 -36 372
Net Income / (Loss) Continuing Operations
82 65 64 69 35 65 -79 45 89 88 77
Consolidated Net Income / (Loss)
82 65 64 69 33 58 -193 11 89 90 77
Net Income / (Loss) Discontinued Operations
- - - - -2.30 -7.26 -113 -35 0.10 1.72 0.00
Depreciation Expense
7.38 12 17 25 34 34 35 34 30 29 28
Amortization Expense
0.31 0.30 0.30 0.29 0.33 0.35 0.42 0.42 0.42 0.58 0.39
Non-Cash Adjustments To Reconcile Net Income
11 7.26 15 15 9.44 -2.43 125 5.96 13 14 3.80
Changes in Operating Assets and Liabilities, net
-53 -9.45 -43 -15 -48 -80 101 31 -257 -167 262
Net Cash From Discontinued Operating Activities
- - - - -6.64 - - - 0.00 0.00 0.00
Net Cash From Investing Activities
-11 -81 -74 -96 -152 -38 -55 32 -3.72 -8.26 9.05
Net Cash From Continuing Investing Activities
-11 -81 -74 -96 -151 -38 -55 32 -3.72 -8.26 9.05
Purchase of Property, Plant & Equipment
-11 -21 -12 -8.85 -7.00 -5.80 -6.39 -2.36 -6.85 -9.98 -8.56
Divestitures
- - - - - 0.00 0.00 34 3.13 1.72 18
Net Cash From Discontinued Investing Activities
- - - - -1.16 - - - 0.00 0.00 0.00
Net Cash From Financing Activities
9.29 -57 -36 -3.51 101 31 -153 -119 108 40 -228
Net Cash From Continuing Financing Activities
9.29 -57 -36 -3.51 101 31 -153 -119 108 40 -228
Repayment of Debt
-4.28 -133 -1,308 -1,794 -2,150 -2,134 -2,196 -1,957 -2,040 -2,442 -1,447
Repurchase of Common Equity
0.00 -19 -100 -21 0.00 -9.48 -6.08 0.00 -18 -16 -43
Issuance of Debt
0.00 94 1,377 1,813 2,301 2,211 2,086 1,882 2,166 2,499 1,260
Other Financing Activities, net
14 1.02 -4.51 -1.94 -50 -36 -36 -43 -0.45 -1.55 1.94
Net Cash From Discontinued Financing Activities
- - - - -0.35 - - - 0.00 0.00 0.00
Effect of Exchange Rate Changes
0.91 -11 -2.60 - - 0.56 -3.64 3.71 -4.76 2.69 -3.64
Cash Interest Paid
0.74 1.08 1.71 2.83 8.61 13 12 6.41 6.07 19 13
Cash Income Taxes Paid
24 36 34 31 36 31 17 12 29 29 27

Quarterly Cash Flow Statements for ScanSource

This table details how cash moves in and out of ScanSource's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Change in Cash & Equivalents
2.49 26 -29 -1.20 6.47 2.34 114 26 -40 -35 36
Net Cash From Operating Activities
-48 -27 55 -15 94 63 160 55 45 -6.19 66
Net Cash From Continuing Operating Activities
-48 -27 55 -15 94 63 160 55 45 -6.19 66
Net Income / (Loss) Continuing Operations
24 26 21 17 15 33 13 16 17 17 17
Consolidated Net Income / (Loss)
24 26 21 19 15 33 13 16 17 17 17
Depreciation Expense
7.23 7.06 7.07 7.26 7.22 7.26 6.74 6.79 7.47 8.13 7.49
Amortization Expense
0.29 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10
Non-Cash Adjustments To Reconcile Net Income
2.44 3.29 4.78 3.53 6.94 -12 3.80 4.67 4.17 7.29 4.69
Changes in Operating Assets and Liabilities, net
-82 -63 22 -43 64 35 137 27 16 -39 36
Net Cash From Investing Activities
-0.68 -3.58 -2.29 -1.71 -2.32 15 -2.42 -1.65 -59 0.77 -1.42
Net Cash From Continuing Investing Activities
-0.68 -3.58 -2.29 -1.71 -2.32 15 -2.42 -1.65 -59 0.77 -1.42
Purchase of Property, Plant & Equipment
-0.68 -3.58 -2.29 -3.43 -2.32 -2.55 -2.42 -1.27 -2.38 -1.97 -1.42
Net Cash From Financing Activities
53 55 -82 14 -83 -78 -43 -24 -27 -26 -31
Net Cash From Continuing Financing Activities
53 55 -82 14 -83 -78 -43 -24 -27 -26 -31
Repayment of Debt
-525 -597 -712 -608 -671 -626 -131 -19 -9.06 -22 -14
Repurchase of Common Equity
- - -11 -4.93 0.00 -1.25 -20 -22 -28 -24 -29
Issuance of Debt
579 653 640 627 589 546 108 17 8.38 18 12
Other Financing Activities, net
-0.59 -1.11 0.12 0.03 -1.51 3.16 0.18 0.11 2.18 2.51 0.00
Effect of Exchange Rate Changes
-1.34 1.38 0.84 1.81 -1.26 1.50 -1.03 -2.86 0.61 -3.38 2.19

Annual Balance Sheets for ScanSource

This table presents ScanSource's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 6/30/2014 6/30/2015 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024
Total Assets
1,335 1,477 1,491 1,718 1,945 2,067 1,692 1,672 1,937 2,068 1,779
Total Current Assets
1,216 1,244 1,229 1,281 1,362 1,477 1,203 1,220 1,524 1,657 1,405
Cash & Equivalents
195 122 61 56 26 19 29 63 38 36 185
Accounts Receivable
464 523 560 637 646 523 443 569 729 753 582
Inventories, net
505 553 559 531 596 554 455 470 615 758 513
Prepaid Expenses
34 47 49 56 95 84 95 118 142 110 125
Plant, Property, & Equipment, net
32 47 52 57 73 0.00 0.00 0.00 0.00 0.00 34
Total Noncurrent Assets
88 186 210 381 510 590 489 452 414 411 341
Goodwill
32 67 93 201 298 311 214 219 214 217 206
Intangible Assets
16 46 51 102 137 121 122 105 84 68 38
Noncurrent Deferred & Refundable Income Taxes
- 39 29 29 22 15 25 22 16 18 20
Other Noncurrent Operating Assets
39 34 37 49 53 113 128 106 99 108 77
Total Liabilities & Shareholders' Equity
1,335 1,477 1,491 1,718 1,945 2,067 1,692 1,672 1,937 2,068 1,779
Total Liabilities
532 668 717 881 1,079 1,153 1,014 940 1,131 1,163 855
Total Current Liabilities
500 599 585 656 710 701 719 733 814 787 669
Short-Term Debt
5.85 12 12 31 44 42 54 7.84 12 6.92 7.86
Accounts Payable
422 501 471 513 563 488 454 635 714 691 588
Current Deferred & Payable Income Tax Liabilities
8.69 4.18 3.06 7.73 13 3.96 5.89 2.50 0.03 9.88 7.90
Other Current Liabilities
64 81 99 105 91 65 77 88 88 79 66
Total Noncurrent Liabilities
33 69 132 225 369 452 295 208 317 376 185
Long-Term Debt
5.43 5.97 77 97 249 323 211 135 260 323 136
Other Noncurrent Operating Liabilities
27 59 52 126 118 97 80 68 54 49 49
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
803 809 774 837 866 914 678 731 807 905 924
Total Preferred & Common Equity
803 809 774 837 866 914 678 731 807 905 924
Preferred Stock
- - - - - 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
803 809 774 837 866 914 678 731 807 905 924
Common Stock
168 157 67 61 68 64 64 71 64 58 26
Retained Earnings
651 716 780 849 882 940 747 758 847 937 1,014
Accumulated Other Comprehensive Income / (Loss)
-17 -65 -73 -73 -84 -90 -133 -98 -105 -90 -116

Quarterly Balance Sheets for ScanSource

This table presents ScanSource's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 9/30/2023 12/31/2023 3/31/2024 9/30/2024 12/31/2024 3/31/2025
Total Assets
2,000 2,131 1,980 1,899 1,781 1,783 1,787 1,703 1,725
Total Current Assets
1,588 1,719 1,578 1,507 1,405 1,416 1,352 1,284 1,310
Cash & Equivalents
40 66 37 43 45 159 145 111 146
Accounts Receivable
745 780 684 692 663 590 567 549 563
Inventories, net
676 762 753 656 575 529 504 492 476
Prepaid Expenses
126 111 103 117 122 138 136 132 125
Plant, Property, & Equipment, net
0.00 0.00 36 0.00 0.00 36 33 30 30
Total Noncurrent Assets
413 411 366 391 376 331 401 389 385
Goodwill
212 214 215 215 208 208 233 228 229
Intangible Assets
79 76 72 64 45 42 78 73 68
Noncurrent Deferred & Refundable Income Taxes
13 15 14 16 19 19 17 18 18
Other Noncurrent Operating Assets
109 106 65 96 103 63 73 70 70
Total Liabilities & Shareholders' Equity
2,000 2,131 1,980 1,899 1,781 1,783 1,787 1,703 1,725
Total Liabilities
1,173 1,268 1,101 983 827 839 866 802 823
Total Current Liabilities
794 837 744 701 611 643 666 610 632
Short-Term Debt
4.10 5.04 5.98 8.21 7.86 7.86 12 9.90 9.60
Accounts Payable
711 749 657 618 541 556 579 520 541
Current Deferred & Payable Income Tax Liabilities
5.27 6.05 4.44 8.11 3.65 4.79 6.38 8.33 13
Other Current Liabilities
74 77 77 67 58 75 69 71 68
Total Noncurrent Liabilities
379 431 357 282 217 196 200 192 192
Long-Term Debt
322 378 305 240 161 138 134 132 130
Other Noncurrent Operating Liabilities
54 51 49 39 56 58 66 60 61
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
827 862 879 915 954 944 921 901 902
Total Preferred & Common Equity
827 862 879 915 954 944 921 901 902
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
827 862 879 915 954 944 921 901 902
Common Stock
66 68 60 60 64 46 2.98 0.00 0.00
Retained Earnings
871 897 918 952 985 998 1,031 1,032 1,023
Accumulated Other Comprehensive Income / (Loss)
-110 -103 -99 -96 -95 -100 -113 -131 -122

Annual Metrics And Ratios for ScanSource

This table displays calculated financial ratios and metrics derived from ScanSource's official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 6/30/2014 6/30/2015 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024
Growth Metrics
- - - - - - - - - - -
Revenue Growth
1.27% 10.47% 9.99% 0.79% -11.31% 2.69% -6.22% 3.38% 12.03% 7.30% -13.94%
EBITDA Growth
113.97% -13.78% 0.70% 11.15% -17.14% 24.89% -122.97% 421.57% 58.58% 8.14% -19.29%
EBIT Growth
135.58% -18.45% -4.42% 4.96% -31.11% 38.74% -168.83% 193.86% 96.87% 11.10% -22.90%
NOPAT Growth
142.50% -17.91% -3.36% -6.22% -35.54% 89.31% -161.90% 206.66% 88.33% 7.54% -29.04%
Net Income Growth
135.96% -20.01% -2.75% 8.84% -52.12% 73.73% -434.49% 105.60% 722.58% 1.14% -14.20%
EPS Growth
130.65% -20.63% 4.85% 13.87% -52.40% 73.64% -438.84% 105.53% 721.43% 2.61% -13.56%
Operating Cash Flow Growth
-63.13% 58.25% -30.87% 81.72% -73.85% -35.37% 1,035.44% -35.85% -206.50% 71.24% 1,139.02%
Free Cash Flow Firm Growth
-82.80% -206.74% -58.51% -48.69% -292.19% 174.51% 17.60% -40.01% -240.26% 55.33% 731.87%
Invested Capital Growth
11.15% 13.97% 13.60% 13.41% 24.67% -5.71% -19.46% -5.69% 28.10% 15.32% -26.37%
Revenue Q/Q Growth
1.58% 3.16% 0.59% 1.13% -16.05% 0.78% 10.87% 7.37% 3.20% -0.40% -5.81%
EBITDA Q/Q Growth
88.04% -10.73% -5.16% 4.66% -0.64% 3.06% -127.79% 332.09% 2.03% -0.16% -4.28%
EBIT Q/Q Growth
97.70% -13.42% -6.64% 4.05% -1.01% 4.42% -188.87% 181.14% 2.89% 0.15% -4.99%
NOPAT Q/Q Growth
100.74% -13.46% -4.95% 8.26% -11.92% 12.45% -180.86% 192.09% -0.06% -1.05% -6.15%
Net Income Q/Q Growth
97.71% -14.01% -5.25% 9.56% -20.56% 2.11% -632.38% 104.69% -4.07% -1.25% -3.40%
EPS Q/Q Growth
98.61% -14.02% -2.86% 9.27% -20.37% 2.28% -634.51% 104.63% -4.43% -0.56% -3.16%
Operating Cash Flow Q/Q Growth
-44.58% 79.01% -28.18% -15.31% 448.56% 147.06% 22.45% -9.74% -893.38% 63.94% 23.21%
Free Cash Flow Firm Q/Q Growth
-71.99% 64.11% -119.98% -76.21% 19.25% 393.62% 55.20% -71.04% -942.69% 43.81% 30.38%
Invested Capital Q/Q Growth
4.11% -2.99% -0.96% 1.94% -2.76% -16.37% -29.99% -3.39% 10.07% 4.03% -5.16%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
10.33% 10.16% 10.04% 10.75% 11.67% 12.09% 11.67% 11.13% 12.08% 11.86% 12.24%
EBITDA Margin
4.43% 3.46% 3.17% 3.49% 3.26% 3.97% -0.97% 3.02% 4.28% 4.31% 4.05%
Operating Margin
4.18% 3.15% 2.74% 2.47% 2.18% 2.92% -2.13% 1.95% 3.46% 3.59% 2.77%
EBIT Margin
4.17% 3.08% 2.67% 2.79% 2.16% 2.92% -2.15% 1.95% 3.42% 3.54% 3.17%
Profit (Net Income) Margin
2.81% 2.03% 1.80% 1.94% 1.05% 1.77% -6.32% 0.34% 2.52% 2.37% 2.36%
Tax Burden Percent
66.44% 65.48% 66.26% 68.23% 52.58% 68.87% 268.41% 18.76% 74.86% 73.70% 77.18%
Interest Burden Percent
101.34% 100.85% 101.40% 102.13% 92.10% 88.06% 109.79% 93.76% 98.19% 90.78% 96.47%
Effective Tax Rate
33.56% 34.52% 33.74% 31.77% 43.76% 22.45% 0.00% 21.11% 25.23% 27.70% 22.82%
Return on Invested Capital (ROIC)
13.76% 10.03% 8.52% 7.04% 3.80% 6.67% -4.71% 5.80% 9.87% 8.78% 6.70%
ROIC Less NNEP Spread (ROIC-NNEP)
13.22% 10.73% 10.02% 25.32% 0.46% -0.86% -92.11% -22.89% 8.24% 5.58% 12.52%
Return on Net Nonoperating Assets (RNNOA)
-2.84% -1.91% -0.48% 1.55% 0.09% -0.20% -19.48% -4.27% 1.68% 1.72% 1.73%
Return on Equity (ROE)
10.92% 8.12% 8.04% 8.59% 3.89% 6.47% -24.20% 1.53% 11.55% 10.49% 8.42%
Cash Return on Invested Capital (CROIC)
3.20% -3.03% -4.22% -5.53% -18.16% 12.55% 16.84% 11.66% -14.77% -5.46% 37.07%
Operating Return on Assets (OROA)
9.72% 7.05% 6.38% 6.19% 3.74% 4.73% -3.48% 3.65% 6.69% 6.70% 5.38%
Return on Assets (ROA)
6.54% 4.65% 4.29% 4.32% 1.81% 2.87% -10.25% 0.64% 4.92% 4.48% 4.01%
Return on Common Equity (ROCE)
10.92% 8.12% 8.04% 8.59% 3.89% 6.47% -24.20% 1.53% 11.55% 10.49% 8.42%
Return on Equity Simple (ROE_SIMPLE)
10.19% 8.09% 8.21% 8.27% 3.83% 6.30% -28.40% 1.48% 11.01% 9.92% 8.34%
Net Operating Profit after Tax (NOPAT)
81 66 64 60 39 73 -45 49 91 98 70
NOPAT Margin
2.78% 2.06% 1.81% 1.69% 1.23% 2.26% -1.49% 1.54% 2.59% 2.59% 2.14%
Net Nonoperating Expense Percent (NNEP)
0.54% -0.70% -1.50% -18.28% 3.34% 7.53% 87.40% 28.69% 1.63% 3.20% -5.82%
Cost of Revenue to Revenue
89.67% 89.84% 89.96% 89.25% 88.33% 87.91% 88.33% 88.87% 87.92% 88.14% 87.76%
SG&A Expenses to Revenue
6.61% 6.56% 6.78% 7.43% 7.34% 7.52% 8.52% 7.85% 7.80% 7.54% 8.51%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
6.15% 7.01% 7.30% 8.28% 9.49% 9.17% 13.80% 9.18% 8.62% 8.27% 9.47%
Earnings before Interest and Taxes (EBIT)
121 99 95 99 68 95 -65 61 121 134 103
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
129 111 112 125 103 129 -30 95 151 163 132
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.35 1.35 1.23 1.22 1.19 0.92 0.90 0.98 0.97 0.81 1.18
Price to Tangible Book Value (P/TBV)
1.44 1.56 1.51 1.91 2.39 1.74 1.78 1.76 1.55 1.19 1.61
Price to Revenue (P/Rev)
0.37 0.34 0.27 0.29 0.33 0.26 0.20 0.23 0.22 0.19 0.34
Price to Earnings (P/E)
13.28 16.65 14.97 14.73 31.08 14.53 0.00 66.36 8.85 8.20 14.21
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
7.53% 6.01% 6.68% 6.79% 3.22% 6.88% 0.00% 1.51% 11.30% 12.20% 7.04%
Enterprise Value to Invested Capital (EV/IC)
1.46 1.40 1.22 1.20 1.14 1.11 0.98 0.98 0.98 0.86 1.19
Enterprise Value to Revenue (EV/Rev)
0.31 0.31 0.28 0.31 0.41 0.36 0.28 0.25 0.29 0.27 0.32
Enterprise Value to EBITDA (EV/EBITDA)
6.99 8.85 8.73 8.76 12.56 9.18 0.00 8.36 6.74 6.30 7.99
Enterprise Value to EBIT (EV/EBIT)
7.43 9.95 10.34 10.99 18.95 12.46 0.00 12.98 8.43 7.67 10.18
Enterprise Value to NOPAT (EV/NOPAT)
11.15 14.84 15.26 18.14 33.43 16.11 0.00 16.43 11.15 10.48 15.11
Enterprise Value to Operating Cash Flow (EV/OCF)
18.91 13.05 18.76 11.51 52.30 73.82 4.65 6.82 0.00 0.00 2.83
Enterprise Value to Free Cash Flow (EV/FCFF)
48.02 0.00 0.00 0.00 0.00 8.57 5.21 8.18 0.00 0.00 2.73
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.01 0.02 0.11 0.15 0.34 0.40 0.39 0.20 0.34 0.36 0.16
Long-Term Debt to Equity
0.01 0.01 0.10 0.12 0.29 0.35 0.31 0.19 0.32 0.36 0.15
Financial Leverage
-0.22 -0.18 -0.05 0.06 0.20 0.24 0.21 0.19 0.20 0.31 0.14
Leverage Ratio
1.67 1.74 1.87 1.99 2.15 2.25 2.36 2.39 2.35 2.34 2.10
Compound Leverage Factor
1.69 1.76 1.90 2.03 1.98 1.98 2.59 2.24 2.30 2.12 2.03
Debt to Total Capital
1.39% 2.20% 10.25% 13.26% 25.23% 28.58% 28.10% 16.37% 25.16% 26.71% 13.48%
Short-Term Debt to Total Capital
0.72% 1.48% 1.34% 3.18% 3.76% 3.32% 5.74% 0.90% 1.08% 0.56% 0.74%
Long-Term Debt to Total Capital
0.67% 0.72% 8.91% 10.08% 21.48% 25.27% 22.36% 15.48% 24.09% 26.15% 12.74%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
98.61% 97.80% 89.75% 86.74% 74.77% 71.42% 71.90% 83.63% 74.84% 73.29% 86.52%
Debt to EBITDA
0.09 0.16 0.79 1.03 2.83 2.84 -8.94 1.50 1.79 2.02 1.09
Net Debt to EBITDA
-1.42 -0.93 0.24 0.58 2.58 2.69 -7.95 0.84 1.54 1.80 -0.31
Long-Term Debt to EBITDA
0.04 0.05 0.69 0.78 2.41 2.51 -7.12 1.42 1.72 1.98 1.03
Debt to NOPAT
0.14 0.27 1.38 2.13 7.54 4.98 -5.83 2.95 2.97 3.36 2.07
Net Debt to NOPAT
-2.27 -1.56 0.42 1.19 6.88 4.72 -5.18 1.66 2.55 2.99 -0.59
Long-Term Debt to NOPAT
0.07 0.09 1.20 1.62 6.41 4.40 -4.64 2.79 2.84 3.29 1.95
Altman Z-Score
5.03 4.58 4.63 4.09 3.35 3.25 3.00 3.45 3.50 3.56 4.09
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.43 2.08 2.10 1.95 1.92 2.11 1.67 1.66 1.87 2.11 2.10
Quick Ratio
1.32 1.08 1.06 1.06 0.95 0.77 0.66 0.86 0.94 1.00 1.15
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
19 -20 -32 -47 -185 138 162 97 -137 -61 386
Operating Cash Flow to CapEx
425.03% 363.75% 432.17% 1,072.17% 354.47% 276.56% 2,850.05% 4,941.47% -1,815.65% -358.44% 4,344.21%
Free Cash Flow to Firm to Interest Expense
25.71 -11.16 -14.97 -14.71 -20.33 10.50 13.29 14.07 -20.96 -3.09 29.61
Operating Cash Flow to Interest Expense
65.28 42.03 24.58 29.51 2.72 1.22 14.89 16.85 -19.06 -1.81 28.52
Operating Cash Flow Less CapEx to Interest Expense
49.92 30.47 18.89 26.76 1.95 0.78 14.37 16.51 -20.11 -2.31 27.86
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
2.33 2.29 2.39 2.22 1.73 1.62 1.62 1.87 1.96 1.89 1.69
Accounts Receivable Turnover
6.48 6.52 6.54 5.96 4.93 5.56 6.31 6.23 5.44 5.11 4.88
Inventory Turnover
5.76 5.47 5.73 5.84 4.96 4.97 5.34 6.05 5.72 4.87 4.50
Fixed Asset Turnover
112.01 82.11 71.55 65.50 48.84 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover
6.66 6.27 6.55 6.47 5.20 5.44 5.71 5.14 4.60 4.75 4.47
Days Sales Outstanding (DSO)
56.34 55.96 55.78 61.21 74.01 65.68 57.88 58.63 67.13 71.44 74.73
Days Inventory Outstanding (DIO)
63.36 66.76 63.70 62.46 73.59 73.46 68.40 60.29 63.80 75.02 81.03
Days Payable Outstanding (DPO)
54.77 58.26 55.75 56.43 70.23 67.13 63.89 70.98 79.33 76.82 81.60
Cash Conversion Cycle (CCC)
64.93 64.47 63.74 67.25 77.37 72.01 62.38 47.93 51.60 69.64 74.16
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
619 706 802 909 1,133 1,069 861 812 1,040 1,199 883
Invested Capital Turnover
4.96 4.86 4.70 4.17 3.10 2.95 3.16 3.77 3.81 3.38 3.13
Increase / (Decrease) in Invested Capital
62 86 96 107 224 -65 -208 -49 228 159 -316
Enterprise Value (EV)
902 986 979 1,092 1,297 1,184 846 797 1,019 1,030 1,053
Market Capitalization
1,086 1,089 952 1,020 1,031 837 611 716 786 736 1,095
Book Value per Share
$28.14 $28.27 $30.18 $33.07 $33.88 $35.56 $26.76 $28.71 $31.96 $36.36 $37.41
Tangible Book Value per Share
$26.45 $24.33 $24.57 $21.12 $16.87 $18.76 $13.51 $16.00 $20.12 $24.90 $27.53
Total Capital
814 827 863 965 1,159 1,280 943 874 1,078 1,235 1,068
Total Debt
11 18 88 128 292 366 265 143 271 330 144
Total Long-Term Debt
5.43 5.97 77 97 249 323 211 135 260 323 136
Net Debt
-184 -103 27 72 267 347 236 80 233 294 -41
Capital Expenditures (CapEx)
11 21 12 8.85 7.00 5.80 6.39 2.36 6.85 9.98 8.56
Debt-free, Cash-free Net Working Capital (DFCFNWC)
527 536 594 599 670 800 509 432 683 841 558
Debt-free Net Working Capital (DFNWC)
722 658 655 655 695 819 539 495 721 877 743
Net Working Capital (NWC)
716 645 644 625 652 776 484 487 710 870 735
Net Nonoperating Expense (NNE)
-0.88 1.01 0.57 -9.04 5.65 16 147 38 2.55 8.43 -7.35
Net Nonoperating Obligations (NNO)
-184 -103 27 72 267 154 182 80 233 294 -41
Total Depreciation and Amortization (D&A)
7.69 12 17 25 35 34 36 34 30 29 28
Debt-free, Cash-free Net Working Capital to Revenue
18.08% 16.65% 16.78% 16.80% 21.17% 24.60% 16.71% 13.71% 19.35% 22.20% 17.11%
Debt-free Net Working Capital to Revenue
24.77% 20.43% 18.51% 18.37% 21.97% 25.20% 17.67% 15.70% 20.43% 23.16% 22.80%
Net Working Capital to Revenue
24.57% 20.05% 18.19% 17.51% 20.60% 23.89% 15.90% 15.45% 20.10% 22.98% 22.56%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$2.89 $2.29 $2.40 $2.74 $1.30 $2.25 ($7.59) $0.42 $3.48 $3.57 $3.10
Adjusted Weighted Average Basic Shares Outstanding
28.34M 28.56M 26.47M 25.32M 25.52M 25.64M 25.38M 25.42M 25.50M 25.14M 24.87M
Adjusted Diluted Earnings per Share
$2.86 $2.27 $2.38 $2.71 $1.29 $2.24 ($7.59) $0.42 $3.45 $3.54 $3.06
Adjusted Weighted Average Diluted Shares Outstanding
28.60M 28.80M 26.69M 25.52M 25.62M 25.73M 25.38M 25.52M 25.76M 25.36M 25.22M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
28.54M 27.62M 25.63M 25.43M 25.59M 25.24M 25.36M 25.50M 25.19M 24.84M 24.03M
Normalized Net Operating Profit after Tax (NOPAT)
72 68 65 64 60 92 44 56 91 98 73
Normalized NOPAT Margin
2.48% 2.12% 1.84% 1.79% 1.88% 2.83% 1.45% 1.78% 2.59% 2.59% 2.24%
Pre Tax Income Margin
4.23% 3.10% 2.71% 2.84% 1.99% 2.57% -2.36% 1.83% 3.36% 3.22% 3.06%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
166.18 55.13 44.58 30.91 7.51 7.22 -5.35 8.86 18.52 6.78 7.94
NOPAT to Interest Expense
110.69 36.96 30.22 18.73 4.25 5.58 -3.72 7.00 14.00 4.97 5.35
EBIT Less CapEx to Interest Expense
150.82 43.57 38.89 28.16 6.74 6.78 -5.87 8.52 17.47 6.28 7.29
NOPAT Less CapEx to Interest Expense
95.33 25.41 24.54 15.97 3.49 5.14 -4.24 6.66 12.95 4.46 4.69
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 28.69% 157.51% 30.16% 0.00% 16.46% -3.15% 0.00% 20.50% 17.43% 55.66%

Quarterly Metrics And Ratios for ScanSource

This table displays calculated financial ratios and metrics derived from ScanSource's official financial filings.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
10.06% 17.03% 4.67% -1.57% -7.15% -12.50% -15.01% -21.23% -11.49% -15.52% -6.34%
EBITDA Growth
10.15% 21.13% 1.55% -0.74% -26.26% 4.88% -41.25% -17.21% -2.41% -44.05% 27.63%
EBIT Growth
13.56% 26.72% 2.62% 0.74% -31.44% 5.25% -48.99% -20.20% -4.25% -54.01% 34.22%
NOPAT Growth
14.23% 16.92% 2.28% -4.73% -25.29% -21.81% -48.54% -21.98% -32.86% -27.21% 28.45%
Net Income Growth
8.92% 10.67% -9.80% -5.69% -35.81% 27.17% -39.65% -14.44% 9.99% -47.89% 36.12%
EPS Growth
9.30% 12.22% -8.79% -2.56% -35.11% 27.72% -39.76% -13.16% 13.11% -45.74% 48.00%
Operating Cash Flow Growth
14.92% -45.97% 84.60% 80.60% 293.01% 335.15% 192.04% 458.69% -52.07% -109.79% -58.75%
Free Cash Flow Firm Growth
-173.12% -56.28% -127.46% 32.71% 105.86% 156.24% 227.53% 337.89% 1,720.44% 30.56% -77.91%
Invested Capital Growth
25.34% 26.57% 22.02% 15.32% 0.70% -8.61% -19.23% -26.37% -17.78% -13.48% -3.83%
Revenue Q/Q Growth
-1.92% 7.14% -12.43% 6.96% -7.48% 0.97% -14.94% -0.86% 3.95% -3.62% -5.71%
EBITDA Q/Q Growth
20.60% 11.33% -11.41% -16.55% -10.41% 58.34% -50.37% 17.59% 5.61% -9.22% 13.20%
EBIT Q/Q Growth
27.68% 14.89% -13.53% -20.58% -13.10% 76.38% -58.09% 24.25% 4.26% -15.28% 22.30%
NOPAT Q/Q Growth
24.50% 7.91% -13.27% -18.24% -2.37% 12.94% -42.92% 23.96% -15.98% 22.45% 0.72%
Net Income Q/Q Growth
20.53% 7.04% -17.54% -11.35% -17.97% 112.07% -60.87% 25.69% 5.45% 0.47% 2.22%
EPS Q/Q Growth
20.51% 7.45% -17.82% -8.43% -19.74% 111.48% -61.24% 32.00% 4.55% 1.45% 5.71%
Operating Cash Flow Q/Q Growth
38.41% 44.52% 303.96% -127.83% 712.89% -32.40% 153.31% -65.82% -18.10% -113.80% 1,167.58%
Free Cash Flow Firm Q/Q Growth
3.94% -10.25% 16.31% 24.08% 108.37% 958.05% 89.78% 41.62% -35.98% -24.12% -67.89%
Invested Capital Q/Q Growth
7.05% 5.91% -2.22% 4.03% -6.53% -3.88% -13.59% -5.16% 4.37% 1.16% -3.95%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
12.02% 11.41% 12.62% 11.47% 12.15% 11.39% 12.55% 13.04% 13.10% 13.61% 14.22%
EBITDA Margin
4.41% 4.59% 4.64% 3.62% 3.51% 5.50% 3.21% 3.80% 3.87% 3.64% 4.37%
Operating Margin
3.70% 3.90% 3.87% 2.88% 2.75% 3.03% 2.33% 2.93% 2.27% 2.47% 3.17%
EBIT Margin
3.62% 3.88% 3.83% 2.84% 2.67% 4.67% 2.30% 2.88% 2.89% 2.54% 3.29%
Profit (Net Income) Margin
2.55% 2.54% 2.40% 1.99% 1.76% 3.70% 1.70% 2.16% 2.19% 2.28% 2.47%
Tax Burden Percent
74.47% 71.10% 70.94% 80.18% 80.60% 81.72% 71.33% 70.92% 73.92% 86.52% 71.95%
Interest Burden Percent
94.56% 92.27% 88.19% 87.10% 81.80% 97.00% 103.76% 105.58% 102.45% 103.81% 104.33%
Effective Tax Rate
25.53% 28.90% 29.06% 27.14% 19.40% 18.28% 28.67% 29.08% 26.08% 13.48% 28.05%
Return on Invested Capital (ROIC)
9.95% 9.89% 9.96% 7.10% 7.38% 7.89% 5.52% 6.51% 5.20% 6.42% 7.43%
ROIC Less NNEP Spread (ROIC-NNEP)
9.04% 8.93% 8.45% 6.70% 5.76% 12.80% 5.75% 6.97% 9.03% 7.83% -6.36%
Return on Net Nonoperating Assets (RNNOA)
2.46% 2.62% 2.06% 2.06% 1.62% 3.10% 0.82% 0.96% 1.01% 0.66% 0.07%
Return on Equity (ROE)
12.41% 12.51% 12.02% 9.16% 9.00% 11.00% 6.35% 7.47% 6.21% 7.08% 7.50%
Cash Return on Invested Capital (CROIC)
-13.04% -14.10% -10.36% -5.46% 7.49% 16.66% 28.41% 37.07% 25.75% 20.12% 10.54%
Operating Return on Assets (OROA)
7.08% 7.48% 7.62% 5.38% 5.10% 8.57% 4.23% 4.88% 4.95% 4.41% 5.59%
Return on Assets (ROA)
4.98% 4.91% 4.77% 3.76% 3.36% 6.80% 3.13% 3.66% 3.75% 3.96% 4.19%
Return on Common Equity (ROCE)
12.41% 12.51% 12.02% 9.16% 9.00% 11.00% 6.35% 7.47% 6.21% 7.08% 7.50%
Return on Equity Simple (ROE_SIMPLE)
10.98% 10.81% 10.35% 0.00% 8.87% 9.25% 8.45% 0.00% 8.54% 6.99% 7.49%
Net Operating Profit after Tax (NOPAT)
26 28 24 20 19 22 13 16 13 16 16
NOPAT Margin
2.75% 2.77% 2.75% 2.10% 2.22% 2.48% 1.66% 2.08% 1.68% 2.13% 2.28%
Net Nonoperating Expense Percent (NNEP)
0.91% 0.96% 1.50% 0.41% 1.62% -4.91% -0.22% -0.46% -3.83% -1.41% 13.79%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - 1.95% - - - 1.53% 1.54%
Cost of Revenue to Revenue
87.98% 88.59% 87.38% 88.53% 87.85% 88.61% 87.45% 86.96% 86.90% 86.39% 85.78%
SG&A Expenses to Revenue
7.59% 6.83% 7.98% 7.85% 8.61% 7.56% 8.85% 9.18% 9.25% 9.89% 9.89%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
8.33% 7.51% 8.75% 8.59% 9.41% 8.35% 10.22% 10.11% 10.83% 11.14% 11.05%
Earnings before Interest and Taxes (EBIT)
34 39 34 27 23 41 17 21 22 19 23
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
42 46 41 34 31 49 24 28 30 27 31
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.80 0.86 0.88 0.81 0.82 1.04 1.17 1.18 1.25 0.00 0.88
Price to Tangible Book Value (P/TBV)
1.24 1.29 1.30 1.19 1.18 1.41 1.60 1.61 1.89 0.00 1.32
Price to Revenue (P/Rev)
0.18 0.20 0.20 0.19 0.20 0.28 0.32 0.34 0.37 0.00 0.27
Price to Earnings (P/E)
7.33 7.91 8.48 8.20 9.27 11.21 13.90 14.21 14.68 0.00 11.81
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
13.65% 12.64% 11.79% 12.20% 10.78% 8.92% 7.20% 7.04% 6.81% 0.00% 8.47%
Enterprise Value to Invested Capital (EV/IC)
0.85 0.89 0.91 0.86 0.86 1.03 1.18 1.19 1.25 0.00 0.88
Enterprise Value to Revenue (EV/Rev)
0.26 0.28 0.27 0.27 0.26 0.31 0.32 0.32 0.37 0.00 0.27
Enterprise Value to EBITDA (EV/EBITDA)
6.14 6.46 6.39 6.30 6.29 7.19 7.95 7.99 8.80 0.00 6.80
Enterprise Value to EBIT (EV/EBIT)
7.62 7.92 7.80 7.67 7.76 8.86 10.06 10.18 11.27 0.00 9.19
Enterprise Value to NOPAT (EV/NOPAT)
10.06 10.68 10.53 10.48 10.48 12.88 14.75 15.11 18.16 0.00 13.07
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 9.02 5.67 3.63 2.83 3.58 0.00 4.96
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 11.45 5.92 3.70 2.73 4.39 0.00 8.23
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.39 0.44 0.35 0.36 0.27 0.18 0.15 0.16 0.16 0.16 0.16
Long-Term Debt to Equity
0.39 0.44 0.35 0.36 0.26 0.17 0.15 0.15 0.15 0.15 0.14
Financial Leverage
0.27 0.29 0.24 0.31 0.28 0.24 0.14 0.14 0.11 0.08 -0.01
Leverage Ratio
2.35 2.39 2.27 2.34 2.24 2.15 2.06 2.10 2.01 1.88 1.90
Compound Leverage Factor
2.22 2.21 2.00 2.04 1.83 2.09 2.14 2.22 2.06 1.95 1.98
Debt to Total Capital
28.30% 30.74% 26.14% 26.71% 21.33% 15.03% 13.38% 13.48% 13.65% 13.61% 13.42%
Short-Term Debt to Total Capital
0.36% 0.40% 0.50% 0.56% 0.71% 0.70% 0.72% 0.74% 1.09% 0.95% 0.92%
Long-Term Debt to Total Capital
27.95% 30.34% 25.64% 26.15% 20.62% 14.33% 12.66% 12.74% 12.56% 12.66% 12.50%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
71.70% 69.26% 73.86% 73.29% 78.67% 84.97% 86.62% 86.52% 86.35% 86.39% 86.58%
Debt to EBITDA
2.11 2.35 1.90 2.02 1.63 1.09 1.06 1.09 1.11 1.29 1.20
Net Debt to EBITDA
1.85 1.94 1.67 1.80 1.35 0.80 -0.10 -0.31 0.00 0.29 -0.06
Long-Term Debt to EBITDA
2.08 2.32 1.86 1.98 1.57 1.04 1.00 1.03 1.02 1.20 1.12
Debt to NOPAT
3.45 3.88 3.13 3.36 2.71 1.95 1.96 2.07 2.29 2.49 2.31
Net Debt to NOPAT
3.02 3.21 2.76 2.99 2.25 1.43 -0.18 -0.59 0.01 0.55 -0.11
Long-Term Debt to NOPAT
3.41 3.83 3.07 3.29 2.62 1.86 1.86 1.95 2.11 2.32 2.15
Altman Z-Score
3.29 3.26 3.55 3.39 3.67 4.12 4.07 3.93 3.88 0.00 3.65
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.00 2.05 2.12 2.11 2.15 2.30 2.20 2.10 2.03 2.11 2.07
Quick Ratio
0.99 1.01 0.97 1.00 1.05 1.16 1.16 1.15 1.07 1.08 1.12
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-199 -219 -184 -139 12 123 234 332 212 161 52
Operating Cash Flow to CapEx
-7,084.65% -751.45% 2,397.81% -444.93% 4,040.30% 2,479.37% 6,617.81% 4,310.16% 1,887.58% -313.63% 4,648.98%
Free Cash Flow to Firm to Interest Expense
-57.72 -43.37 -32.13 -25.06 2.09 36.74 117.04 159.00 100.68 81.79 28.18
Operating Cash Flow to Interest Expense
-14.05 -5.31 9.60 -2.74 16.75 18.82 80.04 26.24 21.26 -3.14 35.98
Operating Cash Flow Less CapEx to Interest Expense
-14.25 -6.02 9.20 -3.36 16.33 18.06 78.83 25.63 20.13 -4.14 35.21
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.96 1.93 1.99 1.89 1.91 1.84 1.84 1.69 1.71 1.74 1.70
Accounts Receivable Turnover
5.42 5.40 5.73 5.11 5.18 4.98 5.43 4.88 5.02 4.99 5.16
Inventory Turnover
5.44 5.01 4.99 4.87 4.92 4.74 4.76 4.50 4.77 4.92 5.12
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00 96.03 0.00 0.00 0.00 90.68
Accounts Payable Turnover
4.84 4.73 4.92 4.75 4.93 4.91 5.03 4.47 4.62 4.95 4.69
Days Sales Outstanding (DSO)
67.35 67.54 63.68 71.44 70.48 73.25 67.20 74.73 72.72 73.19 70.73
Days Inventory Outstanding (DIO)
67.16 72.86 73.19 75.02 74.16 77.07 76.69 81.03 76.58 74.14 71.30
Days Payable Outstanding (DPO)
75.42 77.12 74.22 76.82 73.97 74.32 72.54 81.60 78.96 73.72 77.77
Cash Conversion Cycle (CCC)
59.09 63.28 62.65 69.64 70.67 76.00 71.36 74.16 70.34 73.61 64.27
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,113 1,179 1,153 1,199 1,121 1,077 931 883 921 932 895
Invested Capital Turnover
3.61 3.57 3.63 3.38 3.33 3.19 3.32 3.13 3.09 3.01 3.26
Increase / (Decrease) in Invested Capital
225 247 208 159 7.75 -101 -222 -316 -199 -145 -36
Enterprise Value (EV)
951 1,054 1,045 1,030 958 1,113 1,095 1,053 1,155 0.00 791
Market Capitalization
665 738 772 736 753 989 1,109 1,095 1,154 0.00 798
Book Value per Share
$32.83 $34.16 $34.67 $36.36 $36.84 $38.19 $37.51 $37.41 $38.32 $37.83 $38.43
Tangible Book Value per Share
$21.30 $22.66 $23.33 $24.90 $25.62 $28.04 $27.61 $27.53 $25.39 $25.21 $25.79
Total Capital
1,153 1,245 1,190 1,235 1,163 1,122 1,090 1,068 1,066 1,043 1,042
Total Debt
326 383 311 330 248 169 146 144 146 142 140
Total Long-Term Debt
322 378 305 323 240 161 138 136 134 132 130
Net Debt
286 316 274 294 205 124 -13 -41 0.52 31 -6.53
Capital Expenditures (CapEx)
0.68 3.58 2.29 3.43 2.32 2.55 2.42 1.27 2.38 1.97 1.42
Debt-free, Cash-free Net Working Capital (DFCFNWC)
757 821 802 841 772 757 622 558 553 574 542
Debt-free Net Working Capital (DFNWC)
798 887 839 877 815 802 781 743 698 684 688
Net Working Capital (NWC)
794 882 833 870 806 795 773 735 686 674 678
Net Nonoperating Expense (NNE)
1.94 2.30 3.10 1.07 3.98 -11 -0.29 -0.58 -3.94 -1.10 -1.36
Net Nonoperating Obligations (NNO)
286 316 274 294 205 124 -13 -41 0.52 31 -6.53
Total Depreciation and Amortization (D&A)
7.52 7.15 7.17 7.35 7.31 7.36 6.84 6.89 7.57 8.23 7.59
Debt-free, Cash-free Net Working Capital to Revenue
20.94% 21.81% 21.09% 22.20% 20.75% 21.08% 17.97% 17.11% 17.50% 18.98% 18.22%
Debt-free Net Working Capital to Revenue
22.06% 23.58% 22.07% 23.16% 21.90% 22.33% 22.57% 22.80% 22.10% 22.64% 23.13%
Net Working Capital to Revenue
21.95% 23.45% 21.91% 22.98% 21.68% 22.11% 22.34% 22.56% 21.73% 22.31% 22.81%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.95 $1.02 $0.84 $0.76 $0.62 $1.31 $0.51 $0.66 $0.70 $0.72 $0.75
Adjusted Weighted Average Basic Shares Outstanding
25.20M 25.29M 25.20M 25.14M 24.89M 25.04M 25.03M 24.87M 24.15M 23.81M 23.28M
Adjusted Diluted Earnings per Share
$0.94 $1.01 $0.83 $0.76 $0.61 $1.29 $0.50 $0.66 $0.69 $0.70 $0.74
Adjusted Weighted Average Diluted Shares Outstanding
25.45M 25.50M 25.44M 25.36M 25.18M 25.33M 25.44M 25.22M 24.65M 24.22M 23.60M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
25.25M 25.35M 24.90M 24.84M 24.97M 25.17M 24.71M 24.03M 0.00 23.46M 22.60M
Normalized Net Operating Profit after Tax (NOPAT)
26 28 24 20 19 22 15 16 17 17 17
Normalized NOPAT Margin
2.75% 2.77% 2.75% 2.10% 2.22% 2.48% 2.03% 2.08% 2.16% 2.30% 2.37%
Pre Tax Income Margin
3.42% 3.58% 3.38% 2.48% 2.19% 4.53% 2.39% 3.04% 2.96% 2.64% 3.44%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
9.90 7.75 5.93 4.84 4.19 12.29 8.65 10.31 10.63 9.64 12.65
NOPAT to Interest Expense
7.54 5.54 4.26 3.57 3.48 6.53 6.25 7.44 6.18 8.10 8.75
EBIT Less CapEx to Interest Expense
9.70 7.04 5.53 4.23 3.78 11.53 7.44 9.70 9.50 8.64 11.87
NOPAT Less CapEx to Interest Expense
7.34 4.83 3.86 2.96 3.06 5.77 5.04 6.83 5.05 7.10 7.98
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 19.32% 22.42% 17.43% 0.00% 19.17% 32.72% 55.66% 90.36% 149.35% 152.45%

Key Financial Trends

ScanSource reported mixed results in Q3 2025 versus its prior-year period. Revenue fell modestly, but profitability and free cash flow improved. The company remains in a net cash position with low leverage, supporting its financial flexibility.

  • Gross margin increased to 14.2% in Q3 2025 from 13.0% in Q3 2024, driven by lower cost of revenue.
  • Operating income rose to $22.3 million versus $17.5 million a year ago, reflecting improved operating efficiency.
  • Net income climbed 36% year-over-year to $17.4 million, lifting diluted EPS to $0.74.
  • Free cash flow to firm (FCFF) was $51.7 million in Q3 2025, supporting capital returns or debt reduction.
  • Net debt was negative $6.5 million, as cash and equivalents of $146 million exceed total debt of $139.8 million.
  • Total revenue declined 6.3% year-over-year to $704.8 million, weighed by softer end-market demand.
  • Operating cash flow was $66.1 million, impacted by large working capital movements.
  • Leverage remains low with net debt to EBITDA of –0.06x and debt to EBITDA of 1.2x.
  • Quarterly revenue growth was negative for the third consecutive quarter, highlighting cyclical volatility.
  • No dividend was paid in Q3 2025, and capital return has been limited despite strong free cash flow.
07/09/25 01:46 AMAI Generated. May Contain Errors.

Frequently Asked Questions About ScanSource's Financials

When does ScanSource's fiscal year end?

According to the most recent income statement we have on file, ScanSource's financial year ends in June. Their financial year 2024 ended on June 30, 2024.

How has ScanSource's net income changed over the last 10 years?

ScanSource's net income appears to be on a downward trend, with a most recent value of $77.06 million in 2024, falling from $81.79 million in 2014. The previous period was $89.81 million in 2023. View ScanSource's forecast to see where analysts expect ScanSource to go next.

What is ScanSource's operating income?
ScanSource's total operating income in 2024 was $90.32 million, based on the following breakdown:
  • Total Gross Profit: $399.05 million
  • Total Operating Expenses: $308.73 million
How has ScanSource's revenue changed over the last 10 years?

Over the last 10 years, ScanSource's total revenue changed from $2.91 billion in 2014 to $3.26 billion in 2024, a change of 11.9%.

How much debt does ScanSource have?

ScanSource's total liabilities were at $854.78 million at the end of 2024, a 26.5% decrease from 2023, and a 60.5% increase since 2014.

How much cash does ScanSource have?

In the past 10 years, ScanSource's cash and equivalents has ranged from $19.31 million in 2019 to $194.85 million in 2014, and is currently $185.46 million as of their latest financial filing in 2024.

How has ScanSource's book value per share changed over the last 10 years?

Over the last 10 years, ScanSource's book value per share changed from 28.14 in 2014 to 37.41 in 2024, a change of 32.9%.



This page (NASDAQ:SCSC) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners